stockrow
Friday 6 November 2026
Export SNN’s income statement to Excel — free account
Smith & Nephew SNATS, Inc.
SNN Healthcare Medical Devices
Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.
31.12
0.89
−2.78%
Follow SNN
Alert me
Smith & Nephew SNATS, Inc. (SNN) Gross margin
Smith & Nephew SNATS, Inc.'s gross margin over the twelve months to 30 June 2023 was 70.5%. Over the past ten years it has ranged from 68.0% (fiscal 2025) to 75.3% (fiscal 2015) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 68.0% | (1.63) |
| FY2024 | 69.6% | 0.82 |
| FY2023 | 68.8% | (1.65) |
| FY2022 | 70.5% | 0.07 |
| FY2021 | 70.4% | 1.01 |
| FY2020 | 69.4% | (4.57) |
| FY2019 | 74.0% | 0.43 |
| FY2018 | 73.5% | (0.28) |
| FY2017 | 73.8% | 1.05 |
| FY2016 | 72.8% | (2.57) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2023 | 69.4% | (1.26) |
| Dec 2022 | 70.7% | 0.44 |
| Jun 2022 | 70.2% | (1.55) |
| Dec 2021 | 71.8% | 2.79 |
| 6 more quarters | Free account |
Against its own ten years
Low 68.0%
High 75.3%
Ten-year median
70.5%
Current reading's percentile
9
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation compare | 81.1% |
| PODD Insulet Corporation compare | 71.9% |
| SNN Smith & Nephew SNATS, Inc. | 70.5% |
| TXG 10x Genomics compare | 70.0% |
| GMED Globus Medical, Inc. compare | 69.1% |
| PEN Penumbra, Inc. compare | 68.0% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 51.3% |
| BIO Bio-Rad Laboratories, Inc. compare | 51.3% |
| BRKR Bruker Corporation compare | 47.7% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on SNN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement